• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
COVID-19 and Transplant Patients: Challenges, Risks, and Evolving Strategies.新型冠状病毒肺炎与移植患者：挑战、风险及不断演变的策略
Vaccines (Basel). 2025 Mar 17;13(3):318. doi: 10.3390/vaccines13030318.
2
Correlation between the migration scale index and the number of new confirmed coronavirus disease 2019 cases in China.中国新型冠状病毒病新增确诊病例数与迁移规模指数的相关性。
Epidemiol Infect. 2020 May 19;148:e99. doi: 10.1017/S0950268820001119.
3
Dynamics of the coronavirus disease 2019 (COVID-19) epidemic in Wuhan City, Hubei Province and China: a second derivative analysis of the cumulative daily diagnosed cases during the first 85 days.湖北省武汉市及中国2019年冠状病毒病（COVID-19）疫情动态：前85天累计每日确诊病例的二阶导数分析
Glob Health J. 2021 Mar;5(1):4-11. doi: 10.1016/j.glohj.2021.02.001. Epub 2021 Feb 6.
4
Using the COVID-19 to influenza ratio to estimate early pandemic spread in Wuhan, China and Seattle, US.利用新冠病毒与流感的比例来估计中国武汉和美国西雅图早期大流行的传播情况。
EClinicalMedicine. 2020 Sep;26:100479. doi: 10.1016/j.eclinm.2020.100479. Epub 2020 Aug 12.
5
Estimating internationally imported cases during the early COVID-19 pandemic.估算新冠疫情早期的国际输入病例数。
medRxiv. 2020 Jul 17:2020.03.23.20038331. doi: 10.1101/2020.03.23.20038331.
6
Effect of Travel Restrictions of Wuhan City Against COVID-19: A Modified SEIR Model Analysis.武汉市对 COVID-19 实施旅行限制的效果：改进的 SEIR 模型分析。
Disaster Med Public Health Prep. 2022 Aug;16(4):1431-1437. doi: 10.1017/dmp.2021.5. Epub 2021 Jan 8.
7
SARS-CoV-2 Antibody Seroprevalence in Wuhan, China, from 23 April to 24 May 2020.2020 年 4 月 23 日至 5 月 24 日中国武汉 SARS-CoV-2 抗体血清阳性率。
mSphere. 2021 Apr 21;6(2):e01062-20. doi: 10.1128/mSphere.01062-20.
8
Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City, China, January-February, 2020.2020 年 1 月至 2 月中国武汉市 2019 年冠状病毒病（COVID-19）传播潜力和毒力的早期流行病学评估。
BMC Med. 2020 Jul 15;18(1):217. doi: 10.1186/s12916-020-01691-x.
9
Using Open-Source Intelligence to Detect Early Signals of COVID-19 in China: Descriptive Study.利用开源情报在中国检测 COVID-19 的早期信号：描述性研究。
JMIR Public Health Surveill. 2020 Sep 18;6(3):e18939. doi: 10.2196/18939.
10
Estimating asymptomatic, undetected and total cases for the COVID-19 outbreak in Wuhan: a mathematical modeling study.估算武汉 COVID-19 疫情中的无症状、未检出和总病例数：一项数学建模研究。
BMC Infect Dis. 2021 May 25;21(1):476. doi: 10.1186/s12879-021-06078-8.

本文引用的文献

1
The role of artificial intelligence in pandemic responses: from epidemiological modeling to vaccine development.人工智能在大流行应对中的作用：从流行病学建模到疫苗研发。
Mol Biomed. 2025 Jan 3;6(1):1. doi: 10.1186/s43556-024-00238-3.
2
COVID-19 vaccine hesitancy worldwide and its associated factors: a systematic review and meta-analysis.全球范围内对新冠病毒疫苗的犹豫态度及其相关因素：一项系统综述和荟萃分析
Sci One Health. 2023 Nov 14;2:100048. doi: 10.1016/j.soh.2023.100048. eCollection 2023.
3
COVID-19 vaccines: history of the pandemic's great scientific success and flawed policy implementation.COVID-19 疫苗：大流行病的伟大科学成功和有缺陷的政策实施的历史。
Monash Bioeth Rev. 2024 Jun;42(1):28-54. doi: 10.1007/s40592-024-00189-z. Epub 2024 Mar 9.
4
XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1.XBB.1.5 单价 mRNA 疫苗加强针可诱导针对 XBB 亚谱系和 JN.1 的强大中和抗体。
Cell Host Microbe. 2024 Mar 13;32(3):315-321.e3. doi: 10.1016/j.chom.2024.01.014. Epub 2024 Feb 19.
5
The development of COVID-19 treatment.COVID-19 治疗的发展。
Front Immunol. 2023 Jan 26;14:1125246. doi: 10.3389/fimmu.2023.1125246. eCollection 2023.
6
Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis.COVID-19 疫苗在实体器官移植受者中的免疫原性：系统评价和荟萃分析。
Clin Microbiol Infect. 2023 Apr;29(4):441-456. doi: 10.1016/j.cmi.2022.12.004. Epub 2022 Dec 9.
7
COVID-19 Mortality in Vaccinated vs. Unvaccinated Liver & Kidney Transplant Recipients: A Single-Center United States Propensity Score Matching Study on Historical Data.接种疫苗与未接种疫苗的肝移植和肾移植受者的COVID-19死亡率：一项基于美国单中心历史数据的倾向评分匹配研究。
Vaccines (Basel). 2022 Nov 13;10(11):1921. doi: 10.3390/vaccines10111921.
8
Mortality rate of COVID-19 infection in end stage kidney disease patients on maintenance hemodialysis: A systematic review and meta-analysis.维持性血液透析的终末期肾病患者中新冠病毒感染的死亡率：一项系统评价和荟萃分析。
World J Virol. 2022 Sep 25;11(5):352-361. doi: 10.5501/wjv.v11.i5.352.
9
The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future.COVID-19期间远程医疗的全球影响：当前证据及未来建议
Connect Health. 2022 Jan 4;1:7-35. doi: 10.20517/ch.2021.03.
10
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.BNT162b2 mRNA COVID-19 疫苗加强针在预防以色列重症结局的有效性：一项观察性研究。
Lancet. 2021 Dec 4;398(10316):2093-2100. doi: 10.1016/S0140-6736(21)02249-2. Epub 2021 Oct 29.

新型冠状病毒肺炎与移植患者：挑战、风险及不断演变的策略

COVID-19 and Transplant Patients: Challenges, Risks, and Evolving Strategies.

作者信息

Campise Mariarosaria

机构信息

Department of Nephrology, Dialysis and Kidney Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

出版信息

Vaccines (Basel). 2025 Mar 17;13(3):318. doi: 10.3390/vaccines13030318.

DOI:10.3390/vaccines13030318
PMID:40266237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11945915/
Abstract

The first cases of COVID-19 were reported in December 2019 in Wuhan, China [...].

摘要

2019年12月，中国武汉报告了首例新型冠状病毒肺炎病例[……]